Amy Wagers
Senior Investigator and Co-chair at Harvard Department of Stem Cell and Regenerative Biology
Dr. Amy Wagers seeks to change the way we repair our tissues after an injury. Her laboratory’s research focuses on defining the factors and mechanisms that regulate the migration, expansion, and regenerative potential of adult blood-forming and muscle-forming stem cells.
Amy Wagers received her Ph.D. in Immunology and Microbial Pathogenesis from Northwestern University in 1999, and completed her postdoctoral fellowship in the laboratory of Dr. Irving Weissman at Stanford University School of Medicine. In May 2004, she joined the faculty at Harvard Medical School as an Assistant Professor of Pathology and an Investigator at the Joslin Diabetes Center. In 2008, she moved to Harvard’s Department of Stem Cell and Regenerative Biology, and in 2012 became the Forst Family Professor of Stem Cell and Regenerative Biology.
Visit website: https://hscrb.harvard.edu/people/amy-wagers/
See also: Harvard Stem Cell Institute (HSCI) - Research institute affiliated to Harvard University.
Details last updated 12-Nov-2019
Amy Wagers News
Elevian raises $5.5 million in seed funding
MIT Technology Review - 06-Sep-2018
Investigating ability of GDF11 to rejuvenate the body
Read more...Young blood as a key to living longer
Wired - 09-May-2018
GDF11 is a protein in the blood, which can stimulate cell growth and repair
Read more...Pay-to-participate young-blood transfusion clinical trial
STAT - 02-Mar-2018
Bill Faloon inviting people to join a pay-to-participate clinical trial. Will test transfusions ...
Read more...Silicon Valley Is Trying to Make Humans Immortal—and Finding Some Success
Newsweek - 05-Mar-2015
Read more...